secwatch.observer — SEC 8-K summary
======================================

Issuer:     THC Therapeutics, Inc. (—)
CIK:        0001404935
Form:       8-K
Filed at:   2025-07-17T23:59:59+00:00
Accession:  0001477932-25-005094
Event type: m_and_a
Sentiment:  positive
Materiality: 0.70
Item codes: 1.01, 2.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

THC Therapeutics acquires SugarTop Buddery in all-share deal valued at ~$3M
---------------------------------------------------------------------------

- Acquired 100% of ST Holdings Group (SugarTop Buddery) for 3,000 Series D Preferred shares valued at ~$3M.
- SugarTop Buddery generated ~$2.1M in 2024 revenue (peak $4.3M in 2022); 10-year craft cannabis brand.
- Founder/CEO Anna Kaplan joins THCT; brand noted for female-founded leadership and music-inspired craft cannabis.
- This is THCT's second strategic acquisition in 2025, following The Headquarters Group in June.
- THCT expands Oregon operations, targeting a bi-coastal national cannabis platform.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1404935/000147793225005094/0001477932-25-005094-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1404935/000147793225005094/thct_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-25-005094

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer